Trial Profile
A study to evaluate the efficacy and safety of canagliflozin (CANA) added concomitantly with insulin therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Mar 2016
Price :
$35
*
At a glance
- Drugs Canagliflozin (Primary) ; Insulin
- Indications Diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 14 Mar 2016 New trial record